ADAR1 Capital Management’s Korro Bio KRRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.35M Hold
540,054
– – 0.23% 99
2026
Q2
$7.12M Hold
540,054
– – 0.33% 75
2026
Q1
$6.11M Buy
+540,054
New +$5.95M 0.36% 63
2025
Q4
– Sell
-40,235
Closed -$1.93M – 282
2025
Q3
$1.93M Sell
40,235
-28,580
-42% -$634K 0.18% 80
2025
Q2
$859K Buy
68,815
+100
+0.1% +$1.44K 0.13% 94
2025
Q1
$1.2M Buy
68,715
+10,737
+19% +$318K 0.22% 75
2024
Q4
$2.21M Buy
57,978
+8,527
+17% +$438K 0.44% 45
2024
Q3
$1.65M Buy
49,451
+42,241
+586% +$1.78M 0.27% 55
2024
Q2
$244K Buy
+7,210
New +$398K 0.05% 132

Other funds holding KRRO

ADAR1 Capital Management's KRRO Position: Q3 2026 in Review

ADAR1 Capital Management held its Korro Bio (KRRO) position steady in Q3 2026 at 540,054 shares worth $5.35M. The position accounts for 0.23% of the portfolio, ranked #99.

ADAR1 Capital Management first reported a position in KRRO in Q2 2024 and has held it in 9 quarters since. The position peaked at $7.12M in Q2 2026. 105 funds tracked by Wall St. Rank hold KRRO as of Q3 2026.

  • ADAR1 Capital Management held 540,054 shares of Korro Bio worth $5.35M as of Q3 2026.
  • ADAR1 Capital Management left its Korro Bio share count unchanged in Q3 2026.
  • Korro Bio made up 0.23% of ADAR1 Capital Management's portfolio in Q3 2026, its #99 holding.
  • ADAR1 Capital Management first reported a position in Korro Bio in Q2 2024 and has held it in 9 quarters since.
  • ADAR1 Capital Management's Korro Bio position peaked at $7.12M in Q2 2026.
  • 105 funds tracked by Wall St. Rank held Korro Bio as of Q3 2026.

Based on ADAR1 Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.